학술논문

Overexpression of MicroRNA-148b-3p stimulates osteogenesis of human bone marrow-derived mesenchymal stem cells: the role of MicroRNA-148b-3p in osteogenesis
Document Type
Report
Source
BMC Medical Genetics. July 1, 2019, Vol. 20 Issue 1
Subject
Research
Genetic aspects
Stem cells -- Research
Gene expression -- Research
Osteogenesis -- Genetic aspects
Collagen
Fluorescence
Therapeutics
MicroRNA
Genetically modified organisms
Biological markers
Phosphatases
Language
English
ISSN
1471-2350
Abstract
Author(s): Samaneh Mollazadeh[sup.1,2] , Bibi Sedigheh Fazly Bazzaz[sup.2,3,4] , Vajiheh Neshati[sup.2] , Antoine A. F. de Vries[sup.5] , Hojjat Naderi-Meshkin[sup.6] , Majid Mojarad[sup.7,8] , Mahdi Mirahmadi[sup.6] , Zeinab Neshati[sup.9] and [...]
Background Mesenchymal stem cells (MSCs) are attractive choices in regenerative medicine and can be genetically modified to obtain better results in therapeutics. Bone development and metabolism are controlled by various factors including microRNAs (miRs) interference, which are small non-coding endogenous RNAs. Methods In the current study, the effects of forced miR-148b expression was evaluated on osteogenic activity. Human bone marrow-derived mesenchymal stem cells (BM-MSCs) were transduced with bicistronic lentiviral vector encoding hsa-miR-148b-3p or -5p and the enhanced green fluorescent protein. Fourteen days post-transduction, immunostaining as well as Western blotting were used to analyze osteogenesis. Results Overexpression of miR-148b-3p increased the osteogenic differentiation of human BM-MSCs as demonstrated by anenhancement of mineralized nodular formation and an increase in the levels of osteoblastic differentiation biomarkers, alkaline phosphatase and collagen type I. Conclusions Since lentivirally overexpressed miR-148b-3p increased osteogenic differentiation capability of BM-MSCs, this miR could be applied as a therapeutic modulator to optimize bone function. Keywords: Mesenchymal stem cells, Lentivirus, MicroRNA-148b, Osteogenesis